Literature DB >> 9430670

Independent folding and ligand specificity of the C2 calcium-dependent lipid binding domain of cytosolic phospholipase A2.

E A Nalefski1, T McDonagh, W Somers, J Seehra, J J Falke, J D Clark.   

Abstract

The Ca(2+)-dependent lipid binding domain of the 85-kDa cytosolic phospholipase A2 (cPLA2) is a homolog of C2 domains present in protein kinase C, synaptotagmin, and numerous other proteins involved in signal transduction. NH2-terminal fragments of cPLA2 spanning the C2 domain were expressed as inclusion bodies in Escherichia coli, extracted with solvent to remove phospholipids, and refolded to yield a domain capable of binding phospholipid vesicles in a Ca(2+)-dependent manner. Unlike other C2 domains characterized to date, the cPLA2 C2 domain bound preferentially to vesicles comprised of phosphatidylcholine in response to physiological concentrations of Ca2+. Binding of the cPLA2 C2 domain to vesicles in the presence of excess Ca2+ chelator was induced by high concentrations of salts that promote hydrophobic interactions. Despite the selective hydrolysis of arachidonyl-containing phospholipid vesicles by cPLA2, the cPLA2 C2 domain did not discriminate among phospholipid vesicles containing saturated or unsaturated sn-2 fatty acyl chains. Moreover, the cPLA2 C2 domain bound to phospholipid vesicles containing sn-1 and -2 ether linkages and sphingomyelin at Ca2+ concentrations that caused binding to vesicles containing ester linkages, demonstrating that the carbonyl oxygens of the sn-1 and -2 ester linkage are not critical for binding. These results suggest that the cPLA2 C2 domain interacts primarily with the headgroup of the phospholipid. The cPLA2 C2 domain displayed selectivity among group IIA cations, preferring Ca2+ approximately 50-fold over Sr2+ and nearly 10,000-fold over Ba2+ for vesicle binding. No binding to vesicles was observed in the presence of greater than 10 mM Mg2+. Such strong selectivity for Ca2+ over Mg2+ reinforces the view that C2 domains link second messenger Ca2+ to signal transduction events at the membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430670     DOI: 10.1074/jbc.273.3.1365

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  An unusual C(2)-domain in the active-zone protein piccolo: implications for Ca(2+) regulation of neurotransmitter release.

Authors:  S H Gerber; J Garcia; J Rizo; T C Südhof
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  C2 domains from different Ca2+ signaling pathways display functional and mechanistic diversity.

Authors:  E A Nalefski; M A Wisner; J Z Chen; S R Sprang; M Fukuda; K Mikoshiba; J J Falke
Journal:  Biochemistry       Date:  2001-03-13       Impact factor: 3.162

Review 3.  Phospholipase A2 and its potential regulation of islet function.

Authors:  E Simonsson; B Ahrén
Journal:  Int J Pancreatol       Date:  2000-02

Review 4.  Cytosolic phospholipase A₂: physiological function and role in disease.

Authors:  Christina C Leslie
Journal:  J Lipid Res       Date:  2015-04-02       Impact factor: 5.922

5.  Ca2+ activation of the cPLA2 C2 domain: ordered binding of two Ca2+ ions with positive cooperativity.

Authors:  Nathan J Malmberg; Sameer Varma; Eric Jakobsson; Joseph J Falke
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

6.  Cation charge and size selectivity of the C2 domain of cytosolic phospholipase A(2).

Authors:  Eric A Nalefski; Joseph J Falke
Journal:  Biochemistry       Date:  2002-01-29       Impact factor: 3.162

7.  Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha.

Authors:  Pontus K A Forsell; Anders O Olsson; Erik Andersson; Laxman Nallan; Michael H Gelb
Journal:  Biochem Pharmacol       Date:  2005-11-14       Impact factor: 5.858

8.  C2 domains of protein kinase C isoforms alpha, beta, and gamma: activation parameters and calcium stoichiometries of the membrane-bound state.

Authors:  Susy C Kohout; Senena Corbalán-García; Alejandro Torrecillas; Juan C Goméz-Fernandéz; Joseph J Falke
Journal:  Biochemistry       Date:  2002-09-24       Impact factor: 3.162

Review 9.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

10.  Modulation of the activity of cytosolic phospholipase A2alpha (cPLA2alpha) by cellular sphingolipids and inhibition of cPLA2alpha by sphingomyelin.

Authors:  Hiroyuki Nakamura; Shigeo Wakita; Akiko Suganami; Yutaka Tamura; Kentaro Hanada; Toshihiko Murayama
Journal:  J Lipid Res       Date:  2009-10-16       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.